Board MeetingOutcome of Board Meeting
Nath Bio-Genes board met and approved Q1 consolidated results.
Nath Bio-Genes (India) LimitedNATHBIOGEN · Filed with the exchange
Net Profit surged to Rs 32.26 Cr from a loss last quarter, with revenue at Rs 328.40 Cr.
The 33rd Annual General Meeting is scheduled for September 24, 2026.
No comments yet. Be the first.